(Reuters) - Johnson & Johnson and partner Sanofi will stop a late-stage trial of an experimental vaccine to prevent infections caused by the E.coli bacteria due to a lack of sufficient efficacy, the ...
The investigation into the outbreak is ongoing, and officials have said that the contamination source could be outside of the establishment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback